Genocea Biosciences Inc
Biotechnology
Healthcare
GNCA
69.81M shares
NASDAQ US
traded
05 Apr 2022
listed
yes
open
1.43
52 week high
4.01
high
1.44
52 week low
1.33
low
1.31
growth
-39.37%
previous Close
1.38
P/E ratio
-7
market cap
64.91M
div yield
0
usd
Dec 2021
qoq
revenue
net incoming
eps
-0.19
-280.00 %
eps surprise
5.00 %
net profit margin
220.00 %
operating incoming
net change in cash
cash on hand
cost of revenue
top top